Results 71 to 80 of about 5,258 (146)

Unveiling Gut Homeostasis Disruption in Sepsis: Towards an Integrated Mechanistic and Translational Roadmap

open access: yesCell Proliferation, Volume 59, Issue 8, August 2026.
Elucidating the contribution of gut‐organ axes will provide new insights for developing combined therapeutic strategies against sepsis‐associated multiple organ dysfunction. ABSTRACT Sepsis, a life‐threatening clinical syndrome precipitated by a maladaptive host response to infection, is associated with substantial morbidity and high mortality rates ...
Yichen Bao   +7 more
wiley   +1 more source

Comparative study on the virulence of mycobacteriophages

open access: yesJournal of Virology
The global tuberculosis (TB) epidemic affected 10 million people and caused 1.3 million deaths in 2022 alone. Multidrug-resistant TB is successfully treated in less than 60% of cases by long, expensive, and aggressive treatments.
Ilaria Rubino   +10 more
doaj   +1 more source

Efficacy of a phage cocktail in controlling phage resistance development in multidrug resistant Acinetobacter baumannii

open access: yesVirus Research, 2019
The control and treatment of multidrug resistant pathogens infections has become a grand challenge for clinicians worldwide. Virulent phage has long been considered as an effective bactericidal agent, which may be a potentially alternative to antibiotics.
Yuyu, Yuan   +5 more
openaire   +2 more sources

Use of the Naturally Occurring Bacteriophage Grouping Model for the Design of Potent Therapeutic Cocktails

open access: yesAntibiotics
The specificity of phages and their ability to evolve and overcome bacterial resistance make them potentially useful as adjuncts in the treatment of antibiotic-resistant bacterial infections.
Tea Glonti   +7 more
doaj   +1 more source

SocialViruses: integrating quantitative phage–bacteria and phage–phage interaction networks for rational cocktail design

open access: yesBioinformatics Advances
Abstract Motivation Phage therapy is emerging as a promising alternative to antibiotics in biomedical research, highlighting the growing need for computational tools to rationally design effective phage cocktails.
Felipe Molina   +2 more
openaire   +2 more sources

Lytic Activity of Various Phage Cocktails on Multidrug-Resistant Bacteria

open access: yesClinical and Investigative Medicine, 2016
Purpose A bacteriophage is a virus that infects and replicates within a bacterium following the injection of phage genome into the bacterial cytoplasm. They are seen as a possible therapy for multi-drug-resistant strains of many bacteria. The aim of this study is to evaluate the lytic activity of the Pyo, Intesti and Fersisi bacteriophage cocktails on ...
I, Ozkan   +5 more
openaire   +3 more sources

A New Approach for Phage Cocktail Design in the Example of Anti-Mastitis Solution

open access: yesPathogens
The studies on phage therapy have shown an overall protective effect of phages in bacterial infections, thus providing an optimistic outlook on the future benefits of phage-based technologies for treating bacterial diseases.
Daria Królikowska   +9 more
doaj   +1 more source

Ackermannviridae bacteriophage against carbapenem-resistant Klebsiella pneumoniae of capsular type 64

open access: yesFrontiers in Microbiology
Lytic bacteriophages (phages) are promising clinically viable therapeutic options against carbapenem-resistant Klebsiella pneumoniae (CRKP). In China, the predominant strains are those assigned to sequence type 11 and capsular type 64 (ST11-KL64).
Juan Li   +10 more
doaj   +1 more source

FORMULATING PHAGE COCKTAILS AS ADJUVANT THERAPY IN CARBAPENEM-RESISTANT PSEUDOMONAS AERUGINOSA

open access: yesOpen Respiratory Archives
Introduction: Phage-antibiotic synergy (PAS) results in bacterial killing beyond the efficacy of either agent alone. Although the main candidates for therapeutic PAS are lytic phages, temperate phages have been re-evaluated in light of PAS.
Viviane de Cássia Oliveira   +6 more
doaj   +1 more source

Phage Therapy at the Crossroads Between Clinical Promise and Regulatory Challenge

open access: yesPharmaceuticals
Bacteriophage (phage) therapy, including monophage preparations, phage cocktails, engineered phages, and phage-derived enzymes, has re-emerged as a potential option for difficult-to-treat and biofilm-associated infections in the context of rising ...
Anna Gallina   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy